Gregory Dolganov is an experienced leader in molecular diagnostics and biomarker development with a focus on innovation. He has a MD and PhD in Molecular Biology and over 20 years of experience developing multiplex PCR platforms for clinical research applications. Most recently, he was Director of Assay Development at InSilixa where he worked on developing a highly multiplex PCR assay on a microarray-based platform for point-of-care TB diagnostics. He has authored numerous publications and patents in the field.
El lunes 23 de octubre de 2017 celebramos una jornada en la Fundación Ramón Areces sobre Microbiota Intestinal: Implicaciones en la Salud y Enfermedad.
Development of pancreatic cancer organoid model for studying immune response ...TÀI LIỆU NGÀNH MAY
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis...Santhi Devasundaram
The majority of in vitro dormancy experimental models use laboratory-adapted strains H37Rv or Erdman instead of prevalent clinical strains involved during disease outbreaks. Thus, we included the most prevalent clinical strains (S7 and S10) of M. tuberculosis from south India in addition to H37Rv for our in vitro oxygen depletion (hypoxia) experimental model.
Presentation from the 2014 Waterloo iGEM team at the Giant Jamboree in Boston. Read more about Staphylocide, our microbe engineered to silence antiobiotic resistance, on our 2014 wiki: http://2014.igem.org/Team:Waterloo.
This presentation is also available on the iGEM website: http://2014.igem.org/files/presentation/Waterloo_Championship.pdf
The Karolinska Institute (KI) is the largest centre for medical education and research in Sweden and the home of the Nobel Prize in Physiology or Medicine.
KI consists of 22 departments and 600 research groups dedicated to improving human health through research and higher education.
The role of the Kohonen/Grafström team has been to guide the application, analysis, interpretation and storage of so called “omics” technology-derived data within the service-oriented subproject “ToxBank”.
El lunes 23 de octubre de 2017 celebramos una jornada en la Fundación Ramón Areces sobre Microbiota Intestinal: Implicaciones en la Salud y Enfermedad.
Development of pancreatic cancer organoid model for studying immune response ...TÀI LIỆU NGÀNH MAY
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
Proteomics Analysis of Three Different Strains of Mycobacterium tuberculosis...Santhi Devasundaram
The majority of in vitro dormancy experimental models use laboratory-adapted strains H37Rv or Erdman instead of prevalent clinical strains involved during disease outbreaks. Thus, we included the most prevalent clinical strains (S7 and S10) of M. tuberculosis from south India in addition to H37Rv for our in vitro oxygen depletion (hypoxia) experimental model.
Presentation from the 2014 Waterloo iGEM team at the Giant Jamboree in Boston. Read more about Staphylocide, our microbe engineered to silence antiobiotic resistance, on our 2014 wiki: http://2014.igem.org/Team:Waterloo.
This presentation is also available on the iGEM website: http://2014.igem.org/files/presentation/Waterloo_Championship.pdf
The Karolinska Institute (KI) is the largest centre for medical education and research in Sweden and the home of the Nobel Prize in Physiology or Medicine.
KI consists of 22 departments and 600 research groups dedicated to improving human health through research and higher education.
The role of the Kohonen/Grafström team has been to guide the application, analysis, interpretation and storage of so called “omics” technology-derived data within the service-oriented subproject “ToxBank”.
NEW VACCINE HUMAN PAPILLOMAVIRUS DESIGN - BUSINESS PLANCARLOS DUQUE
During my postgraduate research I managed to corroborate an immunological technique with a model in bioinfrmatics. After that analysis linking evolution, immunology, structural biochemistry and bioinformatics, I came up with the idea of developing a vaccine against all human mucosal papilloma viruses through an evolutionary and structural incidence in the design
“I think the biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning.” — Steve Jobs
While analyzing the effects of radio frequency heating on hypothermia in the year 1941, Canadian electrical engineer John Hopps read that if the heart stops beating due to an acute drop in temperature, it could successfully be brought back to life artificially using mechanical or electrical stimulation.
Choose one of the psychological disorders discusseJinElias52
Choose one of the psychological disorders discussed in the text.
In your own words, explain the symptoms of the disorder.
what might cause someone to have this disorder?
This paper should be between 3 and 5 pages.
Single-Dilution COVID-19 Antibody Test with Qualitative and
Quantitative Readouts
Robert H. Bortz III,a Catalina Florez,a,b Ethan Laudermilch,a Ariel S. Wirchnianski,a,c Gorka Lasso,a Ryan J. Malonis,c
George I. Georgiev,c Olivia Vergnolle,c Natalia G. Herrera,c Nicholas C. Morano,c Sean T. Campbell,d,f Erika P. Orner,d,f
Amanda Mengotto,e,f M. Eugenia Dieterle,a J. Maximilian Fels,a Denise Haslwanter,a Rohit K. Jangra,a Alev Celikgil,c
Duncan Kimmel,e,f James H. Lee,c Margarette C. Mariano,c Antonio Nakouzi,a,e,f Jose Quiroz,e,f Johanna Rivera,a,e,f
Wendy A. Szymczak,d,f Karen Tong,c Jason Barnhill,b Mattias N. E. Forsell,g Clas Ahlm,g Daniel T. Stein,f,h
Liise-anne Pirofski,a,e,f D. Yitzchak Goldstein,d,f Scott J. Garforth,c Steven C. Almo,c Johanna P. Daily,a,e,f
Michael B. Prystowsky,d,f James D. Faix,d,f Amy S. Fox,d,f Louis M. Weiss,d,f Jonathan R. Lai,c Kartik Chandrana
aDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA
bDepartment of Chemistry and Life Science, United States Military Academy at West Point, West Point, New York, USA
cDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA
dDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA
eDivision of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
fMontefiore Medical Center, Bronx, New York, USA
gDepartment of Clinical Microbiology, Umeå University, Umeå, Sweden
hDivision of Endocrinology and Diabetes, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
Robert H. Bortz III, Catalina Florez, Ethan Laudermilch, and Ariel S. Wirchnianski made equivalent contributions. They are listed alphabetically.
ABSTRACT The coronavirus disease 2019 (COVID-19) global pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to place an
immense burden on societies and health care systems. A key component of COVID-
19 control efforts is serological testing to determine the community prevalence of
SARS-CoV-2 exposure and quantify individual immune responses to prior SARS-CoV-2
infection or vaccination. Here, we describe a laboratory-developed antibody test that
uses readily available research-grade reagents to detect SARS-CoV-2 exposure in
patient blood samples with high sensitivity and specificity. We further show that this
sensitive test affords the estimation of viral spike-specific IgG titers from a single
sample measurement, thereby providing a simple and scalable method to measure
the strength of an individual’s immune response. The accuracy, adaptability, and
cost-effe ...
Integrating Disruptive Technologies Into Translational Research Hinxton Hal...Mike Romanos
Introduction to a session with the same title. Addresses the challenges in drug discovery and how disruptive technologies can help. Focusses on use of RNAi and stem cells in translational studies
Use the Harvard Business Case, West Jet Airlines Information Tec.docxjessiehampson
Use the Harvard Business Case, “West Jet Airlines: Information Technology Governance and Corporate Strategy," as the basis for answering the following questions:
What was West Jet’s strategic plan?
What were the main problems faced by the West Jet IT organization?
Discuss how West Jet transformed their IT organizational structure. How was the structure itself realigned? What methods and processes were introduced or removed?
Discuss IT governance models that were considered to enable IT to function more efficiently at West Jet.
How does IT affect a company’s corporate strategy and the overall strategic impact?
Business School, Cespedes, Frank & Kindley, James
Minimum 2 scholarly Articles References.
Minimum of 500 Words, APA Format
Your paper will be submitted to Turnitin software, No plagiarism.
Contents lists available at ScienceDirect
Infection, Genetics and Evolution
journal homepage: www.elsevier.com/locate/meegid
Short communication
Genetic diversity and evolution of SARS-CoV-2
Tung Phan⁎
Division of Clinical Microbiology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA, USA
A R T I C L E I N F O
Keywords:
Coronavirus
SARS-CoV-2
Mutations
Genomic diversity
A B S T R A C T
COVID-19 is a viral respiratory illness caused by a new coronavirus called SARS-CoV-2. The World Health
Organization declared the SARS-CoV-2 outbreak a global public health emergency. We performed genetic
analyses of eighty-six complete or near-complete genomes of SARS-CoV-2 and revealed many mutations and
deletions on coding and non-coding regions. These observations provided evidence of the genetic diversity and
rapid evolution of this novel coronavirus.
1. The study
A new coronavirus SARS-CoV-2 is spreading cross the world (Phan,
2020). Since the virus emerged at the seafood wholesale market at the
end of last year (Zhu et al., 2019), the number of infected cases has
been rising dramatically (Velavan and Meyer, 2020). Human-to-human
transmission of SARS-CoV-2 has been confirmed (Nishiura et al., 2020).
The virus has been detected in bronchoalveolar-lavage (Zhu et al.,
2019), sputum (Lin et al., 2020), saliva (K.K. To et al., 2020), throat
(Bastola et al., 2020) and nasopharyngeal swabs (To et al., 2020).
Nucleotide substitution has been proposed to be one of the most
important mechanisms of viral evolution in nature (Lauring and
Andino, 2010). The rapid spread of SARS-CoV-2 raises intriguing
questions such as whether its evolution is driven by mutations. To as-
sess the genetic variation, eighty-six complete or near-complete gen-
omes of SARS-CoV-2 were collected from GISAID [https://www.gisaid.
org/]. These SARS-CoV-2 strains were detected in infected patients
from China (50), USA (11), Australia (5), Japan (5), France (4), Sin-
gapore (3), England (2), Taiwan (2), South Korea (1), Belgium (1),
Germany (1), and Vietnam (1). The pair-wise nucleotide sequence
alignment was performed by ClustalX2 (Saitou and Nei, ...
Use the Harvard Business Case, West Jet Airlines Information Tec.docx
GD-CV+01-24-2017
1. Gregory Dolganov
San Carlos, CA94070
Cell Phone: 650-533-2545
g.dolganov@comcast.net; gregoryd@stanford.edu
------------------------------------------------------------------------------------------------------------------------------------------
Summary. Experienced leader in Molecular diagnostics, Biomarker development, Gene expression Analysis and
Multiplex PCR, wired for innovation and Next-Gen Molecular technologies. MD PhD in Molecular Biology with
extensive experience and focus on innovation technologies for clinical research and life-scienceapplications. During
the last 20 years at Genelabs, UCSF and Stanford developed high Multiplex qRT-PCR gene expression platform for
interrogation of disease-associated genes in small clinical specimens,laser captured/flow-sorted cells,and pathogen
infected clinical specimens.Later atStanford,with FundingfromGates Foundation designed and developed accurate
and sensitive Mtb gene expression profiling in high background of host DNA and RNA. In collaboration with peers
from Broad Institute, Boston University, and other collaborators elsewhere, developed a suite of tools for
multiplatformanalysis of TB-infected clinical specimens.Multipletranscriptomics,proteomics,glycomics,lipidomics
and metabolomics measurements have been obtained of Mtb and of the Mtb-infected host cell and published in
Nature (2013).This very sensitiveand specific assay and the correspondingstatistical and bioinformaticstools have
been extensively used and validated.Actively participated in Translational Research and Applied MedicineProgram
at Stanford. Currently, a high-throughput and highly multiplex assay for point of care diagnostics of Mtb is being
developed under my supervision on Hydra1K platformchosen through growing research collaboration with a small
Silicon Valley start-up InSilixa,founded by academic semi-conductor engineers from Stanford. Since2014 I assumed
the role of Director of Assay Development at InSilixa.Currently I amlookingforward new challenges with hope that
my energy, enthusiasmand my extensive expertise and networking capabilities will makean impacton global health
via development and promotion of novel POC diagnostic platforms. Consulted Cellecta on their new DriverMap
technology and currently involved in the design of new NGS-based gene expression profiling platform for MTB-
infected clinical specimens thatcould be also used as companion assay in drugdevelopment and diagnostics.
2014 – 2016 Director of Research and Development at InSilixa.
Director of Assay Development (collaboration between Stanford and Insilixa) working on POC MDx platform for
Diagnostics of MDR/XDR TB that is based on: (1) Multiplex qPCR, (2) hybridization to cMOS oligonucleotide microarrays
(32x32 biosensors) followed by (3) HR Melt Curve Analysis for detecting Drug Resistant SNPs on the surface of the chip
(current throughput is over 250 SNPs). This platform can be used for POC MDx applications to any pathogen, or even a
host. This could revolutionize translational medicine and bring MDX from bench to bedside to community. This MDx
platform may eventually become a drug companion assay to improve drug screening and help to select drugs for custom
treatment of patients.
2006 - present Senior Research Scientist, Division of Infectious Diseases,Stanford University
Developed Multiplex qRT-PCR for genome-wide gene expression profiling of TB-infected
clinical specimens to study immunopathogenesis of TB in natural human/animal hosts
during the infection, including persistence, or reactivation from latency. Designed more
the than 2,500 assays for MTB genes distinguishing between various strains of TB in
clinical cohorts specimens.
2. 2000 – 2006 Assistant Professor of Medicine, Department of Medicine,Division of Pulmonary and Critical
Care Medicine,
UCSF, San Francisco.
Developed a strategy for identifying disease gene targets based on differential gene
expression analyses in healthy vs. diseased tissues, and functional gene inactivation.
Optimized multiplex real time PCR for gene expression profiling in individual laser-captured
cells from airway submucosa.
Initiated collaborations with PI’s at UCSF, Stanford, Harvard and Primate Research Center at
UC Davis on a number of clinical research projects including asthma, COPD and CF. Used
transcriptional profiling on purified populations of submucosal gland and airway surface
epithelial cells from COPD and CF specimens.
With peers at UCSF validated direct effects of interleukin-13 on epithelial cells that causes
airway hyper reactivity and mucus overproduction in asthma.
Involved in functional studies on cancer targets including members of EGF, BMP and TFG
families in the smokers vs. healthy subjects in asthma and COPD.
Co-founder of Bi-Par Sciences, Inc. acquired by Sanofi-Aventis in 2009.
Other Experience and Professional Memberships
Co-founder: Bi-PARPharmaceuticals(2002)
American Association for theAdvancementof Sciences
American Society for Human Genetics.
PATENTS:
US 4,680,260 (July 14, 1987) Method for producinghuman leukocyte interferon alpha-2 Vladimir GDebabov, et al.
US 4,988,622 (January 29, 1991) Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte
interferon alpha-I1 and strain Pseudomonas sp. 31 (pVN 22) - producer of human leukocyte interferon alpha-I1
containingsameVladimir GDebabov, et al.
US 5,965,427 (October 13, 1998) Transcripts encodingimmunomodulatory polypeptides Dolganov; Gregory (Menlo
Park,CA) - Genelabs Technologies, Inc. (Redwood City, CA).
US 5,821,091(October 13, 1998) Human RAD50 gene and methods of use thereof Dolganov; Gregory (San Carlos,
CA); Novikov; Alexander (Foster City, CA) - Genelabs Technologies, Inc. (Redwood City, CA).
US 5,821,091 (October 12, 1999) Method of identifying activated T-cells Dolganov; Gregory (Menlo Park, CA) -
Genelabs Technologies, Inc. (Redwood City, CA).
Representative Publications:
1. G. M. Dolganov, P.G. Woodruff,A. Novikov, Y. Zhang, R. E. Ferrando,R. Szubin and J.V. Fahy. (2001) A novel
method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na +-
K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Research 11(9): 1473-1483.
3. 2. D.A. Kuperman, X. Huang, L.L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J.A. Elias,D. Sheppard & D.J. Erle
(2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus
overproduction in asthma. Nat. Med. 8 (8): 885-9.
3. DG. Morris,N. Kaminski, X.Huang,SD. Shapiro, G.Dolganov -
mediated TGF-beta activation causes MMP-12-dependent emphysema. Nature 422 (6928):169-173
4. Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B.,
Butcher, P. D. Nathan, C., and Schoolnik, G. K. (2003) Transcriptional Adaptation of Mycobacterium
tuberculosis within Macrophages:Insights into thePhagosomal Environment.JExp Med.198(5):p. 693-704.
5. Voskuil,M.I.,Schnappinger,D., Visconti,K.C.,Harrell,M.I., Dolganov, G. M., Sherman, D. R., and Schoolnik,
G. K. (2003) Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy
Program. J Exp Med. 198(5): 705-13.
6. Voice J, Donnelly S, Dorsam G, Dolganov G, Paul S, Goetzl EJ. (2004) c-Maf and JunB mediation of Th2
differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactiveintestinal peptide.
J Immunol. 172(12): 7289-96.
7. Aurora, A. B., P. Baluk, Zhang, D., Sidhu, S. S., Dolganov, G. M., Basbaum, C., McDonald,D. M., Killeen,N.
(2005). "Immune complex-dependent remodeling of the airway vasculature in response to a chronic
bacterial infection."JImmunol 175(10): 6319-26.
8. Barker, C. S., C. Griffin, Dolganov, G. M., Hanspers, K., Yang, J. Y., Erle, D. J. (2005) "Increased DNA
microarray hybridization specificity usingsscDNAtargets." BMC Genomics 6(1): 57.
9. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick
TP, Pantoja C,Erle DJ, Yamamoto KR, Fahy JV (2007) “Genome-wide profilingidentifies epithelial cell genes
associated with asthma and with treatment response to corticosteroids.” Proc Natl Acad Sci U S A.
104(40):15858-63
10. Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, Finkbeiner WE, Dolganov GM, Widdicombe
JH, Boushey HA, Avila PC (2009) In vitro susceptibility to rhinovirus infection is greater for bronchial than
for nasal airway epithelial cellsin human subjects. JAllergy Clin Immunol. 123(6):1384-90
11. Aagaard,C, Hoang T, Dietrich J, Cardona PJ, Dolganov G, Schoolnik,GK, Cassidy JP,Billeskov R,Andersen P.
(2011) A multi-stage tuberculosis vaccine that confers efficient protection before and after exposure. Nat.
Med. 17: 189-194
12. Marmai C, Sutherland RE, Kim KK, Dolganov GM, Fang X, Kim SS, JiangS, Golden JA, Hoopes CW, Matthay
MA, Chapman HA, Wolters PJ (2011) Alveolar epithelial cellsexpress mesenchymal proteins in patients with
idiopathic pulmonary fibrosis.Am J Physiol LungCell Mol Physiol 301:L71-78.
13. McGuire AM, Weiner B, Park ST, Wapinski I,Raman S, Dolganov G, Peterson M, Riley R, Zucker J, Abeel T,
White J, Sisk P, Stolte C, Koehrsen M, Yamamoto RT, Iacobelli-Martinez M, Kidd MJ, Maer AM, Schoolnik
GK, Regev A, Galagan J (2012) Comparative analysis of Mycobacterium and related Actinomycetes yields
insightinto the evolution of Mycobacterium tuberculosis pathogenesis.BMC Genomics 13:120.
14. Commandeur S,van Meijgaarden KE,Prins C,Pichugin AV,Dijkman K,van den Eeden SJ, Friggen AH, Franken
KL, Dolganov G, Kramnik I,Schoolnik GK,Oftung F, Korsvold GE, Geluk A, Ottenhoff TH. (2013) An unbiased
genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by
human T cells expressed duringpulmonary infection. J Immunol. 190(4):1659-71.
4. 15. Galagan J, Dolganov G, et al. (2013) “The Mycobacterium Tuberculosis Regulatory Network and Hypoxia.”
Nature 499 (7457):178-83.
16. Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK, Lundberg CV, Agger EM, Andersen P
(2013) ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposuretuberculosis vaccination.
PLoS One 2013, 8(12):e80579.
17. Knudsen NP, Norskov-Lauritsen S, Dolganov GM, Schoolnik GK, Lindenstrom T, Andersen P, Agger EM,
Aagaard C (2014) Tuberculosis vaccine with high predicted population coverage and compatibility with
modern diagnostics.Proc Natl Acad Sci U S A 111(3):1096-1101.
18. Garcia B, Walter ND, Dolganov G, Coram M, Davis JL, Schoolnik GK, Strong M (2014) A minimum variance
method for genome-wide data-driven normalization of quantitative real-time polymerase chain reaction
expression data. Anal Biochem 458:11-13.
19. Rienksma, R. A., Suarez-Diez, M., Mollenkopf, H. J., Dolganov, G. M., Dorhoi, A., Schoolnik, G. K., Martins
Dos Santos, V. A., Kaufmann, S. H., Schaap, P. J., Gengenbacher, M. (2015) Comprehensive insights into
transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing. BMC
Genomics 16:34.
20. Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de
Jong BC, Davidson RM,Fingerlin TE, Kechris K,Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi
A, Strong M, Schoolnik GK, Davis JL (2015) Transcriptional Adaptation of Drug-tolerant Mycobacterium
Tuberculosis DuringTreatment of Human Tuberculosis.15;212(6):990-8.
21. Ofori-AnyinamB, Kanuteh F, Agbla SC, Adetifa I, Okoi C, Dolganov G, Schoolnik G, Secka O, Antonio M, de
Jong BC, Gehre F. (2016). "Impact of the Mycobaterium africanumWestAfrica 2 Lineage on TB Diagnostics
in West Africa:Decreased Sensitivity of Rapid Identification Tests in TheGambia."PLoS Negl Trop Dis 10(7):
e0004801.
22. Walter ND, de Jong BC, Garcia BJ, Dolganov GM, Worodria W,Byanyima P, Musisi E, HuangL, Chan ED,
Van TT, Antonio M, Ayorinde A, Kato-Maeda M, Nahid P, Leung AM, Yen A, Fingerlin TE, Kechris K,Strong
M, Voskuil MI,Davis JL, Schoolnik GK. (2016) Adaptation of Mycobacteriumtuberculosis to Impaired Host
Immunity in HIV-Infected Patients.J Infect Dis.214(8):1205-11.
23. Garcia BJ,Loxton AG, Dolganov GM, Van TT, Davis JL, de Jong BC, Voskuil MI,Leach SM, Schoolnik GK,
Walzl G,Strong M, Walter ND. (2016) Sputum is a surrogate for bronchoalveolar lavagefor monitoring
Mycobacterium tuberculosis transcriptional profiles in TBpatients.Tuberculosis (Edinb).100:89-94.
24. Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, Van T, Chen RY, Warwick J, Via LE,
Song T, Lee M, Schoolnik G, Tromp G, Alland D, Barry CE 3rd, Winter J, Walzl G; Catalysis TB–Biomarker
Consortium., Lucas L, Spuy GV, Stanley K, Theart L, Smith B, Burger N, Beltran CG, Maasdorp E, Ellmann A,
Choi H, Joh J, Dodd LE, Allwood B, Kogelenberg C, Vorster M, Griffith-RichardsS.(2016) Persistingpositron
emission tomography lesion activity and Mycobacteriumtuberculosis mRNA after tuberculosis cure.Nat
Med. (10):1094-1100.
25. Coppola M, van Meijgaarden KE, Franken KL, Commandeur S, Dolganov G, Kramnik I, Schoolnik GK,Comas
I, Lund O, Prins C,van den Eeden SJ, Korsvold GE, Oftung F, Geluk A, Ottenhoff TH. (2016) New Genome-
Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens InducingHuman
T-Cell Responses with Classical and Unconventional CytokineProfiles.Sci Rep. 6:37793.